Session ID: 
PHF08

Radical Collaboration breaks down Silos, Drives Innovation

1:50pm - 2:30pm Tuesday, February 12
Orlando - Rosen Centre
Rosen Centre Grand C

Description

Pharma, providers and payers are the three core stakeholders responsible for patient care, and each possesses different yet complementary goals, skills, and resources. Traditionally seen as having conflicting motivations, collaborations aimed at developing and scaling innovative patient-centric solutions offer an ideal platform for these stakeholders to align.

Case in point: In January 2017, Partners HealthCare Pivot Labs, an integrated delivery network, and UCB, a multi-national pharmaceutical company, collaborated around a shared desire to challenge conventional thinking and explore innovative solutions for those with epilepsy.

The duo created an advisory panel to incorporate a variety of voices with lived experiences. This panel included a provider, a patient, and a public health specialist, and guided efforts to shape and determine the path forward.

In this session, speakers will discuss key learnings based on their front-line experience creating shared project goals to improve patient care.

Learning Objectives:

• Whether it’s maintaining market share for pharma or developing and scaling patient-center solutions for providers, effective collaboration requires aligning the value proposition of each partner.
• Once value propositions are aligned, successful innovations draw on the experience, skills, and resources of each contributor.
• Innovation projects involve an emergent process and ambiguity, but it is possible to ensure value for patients, pharma, providers and payers.
This session is part of a special program called HIMSS19 Pharma Forum. Extra fees and separate registration is required.

Speaker(s): 

Senior Director, Innovation,
Center For Connected Health, Partners Healthcare
Agility Enablement Lead,
UCB
CEO,
Damo Consulting Inc

Audience: 

CIO, CTO
Chief Quality, Chief Clin Transformation Officer
Life Sciences Professionals

Level: 

Intermediate